many questions management needs to answer. hope they will at AGM tomorrow. First, not happy that our shares have been diluted with each capital raise. what's status of FDA approval? why 1/3 drop price of this world class asthma monitoring device? how can the device now be produced cheaply enough to make profit while not compromising quality or efficacy? how many sales so far? also, correct me if I'm wrong, didn't institutional investors come in after last capital raise? do we know who these institutional investors are? wouldn't it be good for the market to know their names?
RSH Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
